SC 13G/AAMENDMENTATYRCIK 0001339970
aTYR PHARMA INC
5%+ passive stake (SC 13G/A) filed .
Short-form disclosure of beneficial ownership above 5% by passive investors with no control intent.
New to the SC 13G/A? What it is and how to read oneFiling facts
- Accession number
- 0001623632-26-001548
- Filer
- aTYR PHARMA INC
- Ticker
- ATYR
- CIK
- 0001339970
- Form type
- SC 13G/A
- Form description
- 5%+ passive stake
- Filed at
- October 7, 2026
- Industry
- SIC 2836Biological Products
- Last verified
- October 7, 2026SecFilingDex pulls from EDGAR with daily cadence
Provenance
Authoritative source — SEC EDGAR
https://www.sec.gov/Archives/edgar/data/1339970/000162363226001548/0001623632-26-001548-index.htm ↗Filer's full EDGAR submission history
EDGAR · aTYR PHARMA INC (0001339970) ↗Machine-readable JSON twin (LLM-citation friendly)
/api/filing/0001623632-26-001548.jsonSecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.